- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2661-801X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Construction of a novel quinoxaline as a new class of Nrf2 activator ; volume:13 ; number:1 ; day:24 ; month:9 ; year:2019 ; pages:1-10 ; date:12.2019
BMC chemistry ; 13, Heft 1 (24.9.2019), 1-10, 12.2019
- Urheber
-
Kandasamy, Murugesh
Mak, Kit-Kay
Devadoss, Thangaraj
Thanikachalam, Punniyakoti Veeraveedu
Sakirolla, Raghavendra
Choudhury, Hira
Pichika, Mallikarjuna Rao
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13065-019-0633-4
- URN
-
urn:nbn:de:101:1-2020020222330880596834
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kandasamy, Murugesh
- Mak, Kit-Kay
- Devadoss, Thangaraj
- Thanikachalam, Punniyakoti Veeraveedu
- Sakirolla, Raghavendra
- Choudhury, Hira
- Pichika, Mallikarjuna Rao
- SpringerLink (Online service)
Ähnliche Objekte (12)
Phenethyl Isothiocyanate, a Dual Activator of Transcription Factors NRF2 and HSF1
Copper diethyldithiocarbamate as an activator of Nrf2 in cultured vascular endothelial cells
The integrated stress response effector ATF4 is an obligatory metabolic activator of NRF2
Characterization of RA839, a noncovalent small molecule binder to Keap1 and selective activator of Nrf2 signaling
Jdp2 is a spatiotemporal transcriptional activator of the AhR via the Nrf2 gene battery
A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation
Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers
COPD lung studies of Nrf2 expression and the effects of Nrf2 activators
Synthesis of a Glucokinase Activator
Construction of a Continuous Utility Function for a Class of Preferences
The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction
A computational study to identify Sesamol derivatives as NRF2 activator for protection against drug-induced liver injury (DILI)
Phenethyl Isothiocyanate, a Dual Activator of Transcription Factors NRF2 and HSF1
Copper diethyldithiocarbamate as an activator of Nrf2 in cultured vascular endothelial cells
The integrated stress response effector ATF4 is an obligatory metabolic activator of NRF2
Characterization of RA839, a noncovalent small molecule binder to Keap1 and selective activator of Nrf2 signaling
Jdp2 is a spatiotemporal transcriptional activator of the AhR via the Nrf2 gene battery
A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation
Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers
COPD lung studies of Nrf2 expression and the effects of Nrf2 activators
Synthesis of a Glucokinase Activator
Construction of a Continuous Utility Function for a Class of Preferences
The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction
A computational study to identify Sesamol derivatives as NRF2 activator for protection against drug-induced liver injury (DILI)
Phenethyl Isothiocyanate, a Dual Activator of Transcription Factors NRF2 and HSF1
Copper diethyldithiocarbamate as an activator of Nrf2 in cultured vascular endothelial cells
The integrated stress response effector ATF4 is an obligatory metabolic activator of NRF2
Characterization of RA839, a noncovalent small molecule binder to Keap1 and selective activator of Nrf2 signaling
Jdp2 is a spatiotemporal transcriptional activator of the AhR via the Nrf2 gene battery
A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation
Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers
COPD lung studies of Nrf2 expression and the effects of Nrf2 activators
Synthesis of a Glucokinase Activator
Construction of a Continuous Utility Function for a Class of Preferences
The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction